Skip to main content
Premium Trial:

Request an Annual Quote

Strand to Help Agilent 'Accelerate' GeneSpring Upgrade to Meet 'Evolving' Demand

NEW YORK (GenomeWeb News) — Strand Life Sciences will help Agilent accelerate the upgrade of its GeneSpring software in an attempt to meet “evolving customer needs,” Agilent said yesterday.
 
Terms of the deal call for Strand to employ its Avadis platform to “power the … GeneSpring products and enable rapid development of new functionality and analysis capabilities,” Stand CEO Vijay Chandru said in a statement.
 
The first version of the GeneSpring GX software developed by Strand is scheduled to be released late this year.
 
The deal expands on an existing relationship between Strand and Stratagene, which Agilent acquired in June. Customers of Stratagene's ArrayAssist software will be offered a “migration path” to this new version of GeneSpring.
  
Strand’s “expertise in delivering chemistry and biology software will accelerate our bioinformatics software development and move us toward our number-one goal of providing application and workflow solutions for customers,” Bruce von Herrmann, general manager and vice president of Agilent's Software and Informatics Division, said in the statement.